Physician

Roxanna Sabghi, M.D.

According to 2025 Medicare claims, Roxanna Sabghi, M.D. (NPI: 1073990933) practices rheumatology in the Huntsville, AL market, with the plurality of this provider's patient population coming from Madison, AL. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES OF NORTH ALABAMA, PC (NPI: 1639103666; TIN: 63-0907980) and primary practice location at 35802-1783. Sabghi is affiliated with the Huntsville ACO (ACO ID: A3579), participating under the MSSP model.

Sabghi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 445 traditional Medicare patients, billed 65,404 HCPCS/CPT codes, and received $825,263 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,399 prescription claims across 433 beneficiaries totaling $2,549,389 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 124 records totaling $2,122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,640 to $2,549,389. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$413K$825K2021 Medicare payment: $129,049 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $355,505 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $580,250 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $825,263 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211865,483$129,049
202228321,223$355,505
202334638,248$580,250
202444565,404$825,263

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.5M2016 Drug cost: $4,640 (USD; Tot_Drug_Cst)2017 Drug cost: $4,467 (USD; Tot_Drug_Cst)2018 Drug cost: $55,587 (USD; Tot_Drug_Cst)2019 Drug cost: $354,164 (USD; Tot_Drug_Cst)2020 Drug cost: $261,081 (USD; Tot_Drug_Cst)2021 Drug cost: $90,539 (USD; Tot_Drug_Cst)2022 Drug cost: $255,785 (USD; Tot_Drug_Cst)2023 Drug cost: $1,213,495 (USD; Tot_Drug_Cst)2024 Drug cost: $2,549,389 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161666$4,640
20172371$4,467
20182681$55,587
201964290$354,164
202042216$261,081
202197257$90,539
2022170603$255,785
20233741,769$1,213,495
20244332,399$2,549,389

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more252588$83
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more201324$60
80053Blood test, comprehensive group of blood chemicals254471$10
36415Insertion of needle into vein for collection of blood sample230375$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count310571$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1093,220$803,728
Enbrel SureclickEtanercept782,212$604,306
RinvoqUpadacitinib25750$165,274
TymlosAbaloparatide491,530$144,717
OtezlaApremilast19570$95,085

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.124$2,122ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Roxanna Sabghi, M.D.?

Tedicare shows public-source Medicare data for Roxanna Sabghi, M.D. (NPI 1073990933), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roxanna Sabghi, M.D. have ACO affiliation data?

Roxanna Sabghi, M.D. is shown with ACO affiliation data for Huntsville ACO (MSSP, ACO ID A3579).

What billing organization is linked to Roxanna Sabghi, M.D.?

Roxanna Sabghi, M.D. is linked to RHEUMATOLOGY ASSOCIATES OF NORTH ALABAMA, PC (billing NPI 1639103666) in the available physician profile data.

Does Roxanna Sabghi, M.D. have Open Payments data?

Roxanna Sabghi, M.D. has 124 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.